The aggregate effect of dopamine genes on dependence symptoms among cocaine users: Cross-validation of a candidate system scoring approach

Behavior Genetics

Volumn 42, Issue 4, 2012, Pages 626-635

  Derringer, Jaime ^a   Krueger, Robert F ^b   Dick, Danielle M ^c   Aliev, Fazil ^c,d   Grucza, Richard A ^e   Saccone, Scott ^e   Agrawal, Arpana ^e   Edenberg, Howard J ^f   Goate, Alison M ^e   Hesselbrock, Victor M ^g   Kramer, John R ^h   Lin, Peng ^e   Neuman, Rosalind J ^e   Nurnberger Jr , John I ^f   Rice, John P ^e   Tischfield, Jay A ⁱ   Bierut, Laura J ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d ANKARA UNIVERSITY   (Turkey)

^e WASHINGTON UNIVERSITY   (United States)

^f INDIANA UNIVERSITY   (United States)

^g UNIVERSITY OF CONNECTICUT   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ RUTGERS UNIVERSITY   (United States)

Author keywords

Candidate gene; Cocaine dependence; Dopamine

Indexed keywords

CATECHOL METHYLTRANSFERASE; COCAINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR;

ADULT; ARTICLE; AUTOSOMAL INHERITANCE; CLINICAL FEATURE; COCAINE DEPENDENCE; COMT GENE; CONTROLLED STUDY; DBH GENE; DDC GENE; DOPAMINE GENE; DOPAMINE RECEPTOR D1 GENE; DOPAMINE RECEPTOR D2 GENE; DOPAMINE RECEPTOR D3 GENE; DOPAMINE RECEPTOR D4 GENE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SOLUTE CARRIER FAMILY 6 MEMBER 3 GENE; VALIDATION PROCESS;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE;

EID: 84864620177     PISSN: 00018244     EISSN: 15733297     Source Type: Journal    
DOI: 10.1007/s10519-012-9531-4     Document Type: Article

References (63)

1. Achenbach TM, Krukowski RA, Dumenci L, Ivanova MY (2005) Assessment of adult psychopathology: meta-analyses and implications of cross-informant correlations. Psychol Bull 131:361-382 (Pubitemid 40688251)
2. Amin N, van Dujin CM, Janssens ACJW (2009) Genetic scoring analysis: a way forward in genome wide association studies? Eur J Epidemiol 24:585-587
3. Begleiter H, Reich T, Hesselbrock V, Porjesz B, Li T-K, Schuckit M, Edenberg H, Rice J (1995) The collaborative study on the genetics of alcoholism. Alcohol Health Res World 19:228-236
4. Beuming T, Kniazeff J, Bergmann M et al (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11:780-789
5. Bierut LJ (2007) Genetic variation that contributes to nicotine dependence. Pharmacogenomics 8:881-883 (Pubitemid 47423680)
6. Bierut LJ, Strickland JR, Thompson JR, Afful SE, Cottler LB (2008) Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings. Drug Alcohol Depend 95:14-22
7. Bierut LJ, Agrawal A, Bucholz KK et al (2010) A genome wide association study of alcohol dependence. Proc Natl Acad Sci USA 107:5082-5087
8. Bloch PJ, Nall AH, Weller AE, Ferraro TN, Berrettini WH, Kamman KM, Pettinati HM, Dackis CA, O'Brien CP, Oslin DW, Lohoff FW (2009) Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence. Psychiatr Genet 19:275-276
9. Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Coming DE (2000) Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoact Drugs 32:1-112 (Pubitemid 32005730)
10. Briand LA, Flagel SB, Garcia-Fuster MJ et al (2008) Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 33:2969-2980
11. Bucholz KK, Cadoret R, Cloninger CR et al (1994) A new, semistructured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Study Alcohol 55:149-158 (Pubitemid 24080088)
12. Buckland PR (2008) Will we ever find the genes for addiction? Addiction 103:1768-1776
13. Caine SB, Thomsen M, Gabriel KI et al (2007) Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27:13140-13150 (Pubitemid 350220494)
14. Chen K, Kandel D (2002) Relationship between extent of cocaine use and dependence among adolescents and adults in the United States. Drug Alcohol Depend 68:65-85 (Pubitemid 34880041)
15. Dackis CA, Gold MS (1985) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477 (Pubitemid 16243388)
16. Derauf C, Kekatpure M, Neyzi N, Lester B, Kosofsky B (2009) Neuroimaging of children following prenatal drug exposure. Semin Cell Dev Biol 20:441-454
17. Derringer J, Krueger RF, Dick DM et al (2010) Predicting sensation seeking from dopamine genes: a candidate system approach. Psychol Sci 21:1282-1290
18. Evans DM, Visscher PM, Wray NR (2009) Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. Hum Mol Genet 18:3525-3531
19. Fernàndez-Castillo N, Ribasés M, Roncero C, Casas M, Gonzalvo B, Cormand B (2010) Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample. Psychiatr Genet 20:317-320
20. Ford JD, Gelernter J, DeVoe JS et al (2009) Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. Drug Alcohol Depend 99:193-203
21. Ge D, Goldstein DB (2007) WGAViewer: package of whole genome association annotation. Version 1.10. Durham, NC
22. Gillespie N, Neale M, Prescott C, Aggen S, Kendler K (2007) Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction 102:920-930 (Pubitemid 46802230)
23. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612 (Pubitemid 26052818)
24. Goldman D, Oroszi G, Ducci F (2005) The genetics of addictions: uncovering the genes. Nat Rev Genet 6:521-532 (Pubitemid 40910429)
25. Gray JD (1993) Medical consequences of cocaine. Can Fam Physician 39(1975-1976):1979-1981
26. Haile CN, Kosten TR, Kosten TA (2007) Genetics of dopamine and its contribution to cocaine addiction. Behav Genet 37:119-145 (Pubitemid 46144054)
27. Harford TC, Yi HY, Faden VB, Chen CM (2009) The dimensionality of DSM-IV alcohol used disorders among adolescent and adult drinkers and symptom patterns by age, gender, and race/ethnicity. Alcohol Clin Exp Res 33:868-878
28. Henry DJ, White FJ (1991) Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258:882-890
29. Herzberg I, Valencia-Duarte AV, Kay VA, White DJ, Müller H, Rivas IC, Mesa SC, Cuartas M, Garcia J, Bedova G, Cornejo W, Ruiz-Linares A, Kremeyer B (2010) Association of DRD2 variants and Gilles de la Tourette syndrome in a family-based sample from a South American population isolate. Psychiatr Genet 20:179-183
30. Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V (1999) A validity study of the SSAGA-a comparison with the SCAN. Addiction 94:1361-1370 (Pubitemid 29433794)
31. Hill WG, Goddard ME, Visscher PM (2008) Data and theory point to mainly additive genetic variance for complex traits. PloS Genet 4:e1000008
32. Hnasko TS, Sotak BN, Palmiter RD (2007) Cocaine-conditioned place preference by dopamine-deficient mice is mediated by serotonin. J Neurosci 27:12484-12488 (Pubitemid 350127797)
33. Johnson AD, Handsaker RE, Pulit S, Nizzari MM, O'Donnell CJ, de Bakker PIW (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938-2939
34. Kendler KS, Prescott CA (1998) Cocaine use, abuse and dependence in a population-based sample of female twins. Br J Psychiatry 173:345-350 (Pubitemid 28454823)
35. Kendler KS, Karkowski LM, Neale MC, Prescott CA (2000) Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57:261-269 (Pubitemid 30140435)
36. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
37. Lai IC, Mo GH, Chen ML, Wang YC, Chen JY, Liao DL, Bai YM, Lin CC, Chen TT, Liou YJ (2011) Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychoticinduced tardive dyskinesia in schizophrenia. Eur J Clin Pharmacol 67:383-388
38. Laurie CC, Doheny KF, Mirel DB et al (2010) Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol 34(6):591-602
39. Levran O, Londono D, O'Hara K, Randesi M, Rotrosen J, Casadonte P, Linzy S, Ott J, Adelson M, Kreek MJ (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8:531-540
40. Liu QS, Pu L, Poo MM (2005) Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 437:1027-1031 (Pubitemid 41486984)
41. Munafò MR, Matheson IJ, Flint J (2007) Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 12:454-461 (Pubitemid 46652456)
42. Munafò MR, Yalcin B, Willis-Owen SA, Flint J (2008) Association of the dopamine D4 Receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data. Biol Psychiatry 63:197-206 (Pubitemid 350299323)
43. Munafò MR, Timpson NJ, David SP, Ebrahim S, Lawlow DA (2009) Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res 11:64-76
44. Nemoda Z, Lyons-Ruth K, Szekely A, Bertha E, Faludi G, Sasvari-Szekely M (2010) Association between dopaminergic polymorphisms and borderline personality traits among at-risk adults and psychiatric inpatients. Behav Brain Funct 6:4
45. Nichol PE, Krueger RF, Iacono WG (2007) Investigating gender differences in alcohol problems: a latent trait modeling approach. Alcohol Clin Exp Res 31:783-794 (Pubitemid 46587669)
46. Nutt D, King LA, Saulsbury W, Blakemore C (2007) Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369:1047-1053 (Pubitemid 46436128)
47. Plomin R, Haowrth CM, Davis OS (2009) Common disorders are quantitative traits. Nat Rev Genet 10:872-878
48. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick Nam Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904-909 (Pubitemid 44141658)
49. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P, International Schizophrenia Consortium (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752
50. R Development Core Team (2009) R: a language and environment for statistical computing. Version 2.10.1. R foundation for statistical computing. Vienna, Austria. http://www.R-project.org
51. Robinson JD, Lam CY, Minnix JA, Wetter DW, Tomlinson GE, Minna JD, Chen TT, Cinciripini PM (2007) The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. Pharmacogenomics J 7:266-274 (Pubitemid 47202489)
52. Rocha BA, Fumagalli F, Gainetdinov RR et al (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1:132-137
53. Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996) Opposite modulation of cocaine-seeking behavior by D1-and D2-like dopamine receptor agonists. Science 271:1586-1589 (Pubitemid 26097217)
54. Shaffer HJ, Eber GB (2002) Temporal progression of cocaine dependence symptoms in the US National Comorbidity Survey. Addiction 97:543-554 (Pubitemid 34492748)
55. Sora I, Wichems C, Takahashi N et al (1998) Cocaine reward models: conditioned place preference can be established in dopamineand in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95:7699-7704 (Pubitemid 28293316)
56. Substance abuse and mental health services administration (SAM-HSA) (2009) Results from the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36. Office of spplied studies. Rockville, MD. www.samhsa.gov/
57. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND (2008) The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. Synapse 62:319-324 (Pubitemid 351451799)
58. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411:583-587 (Pubitemid 32531404)
59. van den Bree MB, Johnson EO, Neale MC, Pickens RW (1998) Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend 52:231-241 (Pubitemid 28529581)
60. Volkow ND, Wang GJ, Fischman MW et al (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830 (Pubitemid 27181255)
61. Vukcevic D, Hechter E, Spencer C, Donnelly P (2011) Disease model distortion in association studies. Genet Epidemiol 35:278-290
62. Xu M, Hu XT, Cooper DC et al (1994) Elimination of cocaineinduced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955
63. Zuk O, Hechter E, Sunyaev SR, Lander ES (2012) The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA 109(4):1193-1198